title: A possible survival advantage in adults with acute leukemia receiving ABO-identical platelet transfusions.
abstract: In a small cohort of leukemic patients participating in a randomized trial of ABO-identical vs. ABO-unmatched platelet transfusions, a statistically significant decrease in remission duration and increase in mortality were observed in patients receiving ABO-unmatched platelet transfusions. This difference was unexplained by previously described prognostic factors for remission duration and survival. Further study of this association is warranted.
authors.affiliation: Department of Pathology, University of Rochester Medical Center, NY 14642.
authors.forename: J M
authors.initials: JM
authors.lastname: Heal
authors.forename: N
authors.initials: N
authors.lastname: Kenmotsu
authors.forename: J M
authors.initials: JM
authors.lastname: Rowe
authors.forename: N
authors.initials: N
authors.lastname: Blumberg
mesh_terms: D000017:ABO Blood-Group System; D000208:Acute Disease; D000328:Adult; D006801:Humans; D007938:Leukemia / Q000453:epidemiology / Q000628:therapy*; D008875:Middle Aged; D017713:Platelet Transfusion / Q000379:methods; D016019:Survival Analysis
chemical_list: D000017:ABO Blood-Group System